PreveCeutical's President, Dr. Mak Jawadeker, joined Steve Darling from Proactive Investors to discuss the company successfully completing the design, synthesis and preliminary evaluation of key peptides from its scorpion venom derived peptide research program
PreveCeutical's Chief Research Officer, Dr. Harry Parekh joined Steve Darling from Proactive Investors to talk about the companies progress in the development of their Sol-gel Program.
Dr. Mak Jawadekar spoke with Proactives' Steve Darling regarding our advancements in our Sol-gel drug delivery program.
PreveCeutical's CEO and President, Stephen Van Deventer, discusses with Proactive's Andrew Scott the deal they've struck with private firm Asterion Cannabis Inc to develop medical CBD (cannabidiol) products.
PreveCeutical's CEO and President, Stephen Van Deventer, joined Steve Darling in the Vancouver studio of Proactive Investors to talk about the company’s recent developments.
PreveCeutical's Chief Research Officer, Dr. Harry Parekh, gets in touch with Proactive's Andrew Scott, in regards to Preveceutical's Sol-Gel program
PreveCeutical's Dr. Parekh and Dr. Khaled provide an update on our R&D programs
Network News Wire - Audio Interview with Stephen Van Deventer
Democracy in medicine - Financial Post Article
Proactive Investors Interview with Stephen Van Deventer - Video
Canadian med companies join to further research in Australia
PreveCeutical taps into wellness industry’s fastest growing segment
Gene Therapy Holds Out Hope for Diabetics
PreveCeutical seeing significant hospital interest for breakthrough Cannabidiol treatment - Video
A New Breakthrough in Cannabinoid Drug Delivery
Investment Opportunities in Advanced Bioengineered Drug Delivery
Promising New Approaches in Pain Management
Fast-Growing Cannabis Industry Drives Biotech Research, Innovative Medical Therapy Development
PreveCeutical Medical bidding to be big player in preventive healthcare
Market One Media/BNN interviews CEO Stephen Van Deventer - Video
PreveCeutical is poised for success with preventive health-care approach
Diabetes: Silence the Messenger, Don’t Shoot It!
Top 4 Companies Reinventing Cannabinoid Delivery
Entrepreneur “E-Radio” - Stephen Van Deventer Interview [00:18:21] - July 21, 2017
Winning the War on Diabetes & Obesity: a $2.5 Trillion Solution
PreveCeutical CEO Discusses Long-term Goals in Exclusive Interview
Multifaceted Biotech Company Poised to Begin Trading on Canadian Securities Exchange
How PreveCeutical Medical Wants to Own a $3.8 Trillion Industry — Q&A with CEO Stephen Van Deventer
Cannabis, scorpions, and synthesizing better drugs
A Promising Delivery Platform for CBDs
PreveCeutical Medical Partners to Develop CBD Sol-Gels & Novel Diabetes Treatment, Plans to Go Public